Clinical trial
NightWare Therapeutic Platform for Improving Cardiovascular Health in Adults With Nightmares Associated With PTSD
NCT05365607 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NightWare Therapeutic Platform for Improving Cardiovascular Health in Adults With Nightmares Associated With PTSD
- Lead sponsor
- University of Colorado, Denver
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 24, 2022
- Completion date
- August 18, 2024
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
autonomic dysfunction, cardiovascular diseases, endothelial dysfunction, nightmare, posttraumatic stress disorder, vascular stiffness